Viemed president's LLC sells 136,802 shares

Viemed Healthcare, Inc. President Michael Moore reported open-market sales of Common Shares indirectly held through Moore Faster LLC.

Rhea-AI Filing Summary

Viemed Healthcare, Inc. President Michael Moore reported open-market sales of Common Shares indirectly held through Moore Faster LLC. The LLC sold 31,570 shares on March 18 at a weighted-average price of $9.42, 40,232 shares on March 19 at $9.21, and 65,000 shares on March 20 at $8.77 per share. Footnotes state each reported price is a weighted average for multiple trades in ranges of $9.26–$9.61, $9.04–$9.38, and $8.63–$9.18, respectively. Following these transactions, Moore Faster LLC held 1,585,812 Common Shares indirectly, and Michael Moore also held 189,090 Common Shares directly.

Insider Trade Summary

Net Seller: 136,802 shares

Net Sell 4 txns

Insider Moore Michael

Role President

Sold 136,802 shs ($1.24M)

Type	Security	Shares	Price	Value
Sale	Common Shares	65,000	$8.77	$570K
Sale	Common Shares	40,232	$9.21	$371K
Sale	Common Shares	31,570	$9.42	$297K
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 1,585,812 shares (Indirect, by Moore Faster LLC); Common Shares — 189,090 shares (Direct)

Footnotes (3)

1. F1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.26 to $9.61. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.04 to $9.38. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.
3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.63 to $9.18. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Viemed Healthcare (VMD) report for Michael Moore?

Viemed Healthcare President Michael Moore reported indirect open-market sales of 136,802 Common Shares through Moore Faster LLC over three days. The transactions occurred on March 18, 19, and 20, 2026, at weighted-average prices between $8.77 and $9.42 per share.

How many Viemed Healthcare (VMD) shares did Moore Faster LLC sell and at what prices?

Moore Faster LLC sold 31,570 shares on March 18 at $9.42, 40,232 shares on March 19 at $9.21, and 65,000 shares on March 20 at $8.77. Footnotes clarify these are weighted-average prices across multiple trades within specified price ranges.

How many Viemed Healthcare (VMD) shares does Michael Moore hold after these sales?

After the reported sales, Moore Faster LLC held 1,585,812 Viemed Healthcare Common Shares indirectly. Michael Moore also held 189,090 Common Shares directly, according to the holdings line dated March 18, 2026, in the Form 4 data.

Were the Viemed Healthcare (VMD) insider sales made directly by Michael Moore?

The reported sales were made indirectly through Moore Faster LLC, which holds the shares. The Form 4 lists these transactions as indirect ownership, with the nature of ownership described specifically as “by Moore Faster LLC,” rather than directly by Michael Moore personally.

Were the Viemed Healthcare (VMD) insider sales single trades or multiple transactions?

Each reported price is a weighted average of multiple trades. Footnotes explain the March 18, 19, and 20 sales occurred in numerous transactions within price ranges of $9.26–$9.61, $9.04–$9.38, and $8.63–$9.18, respectively, rather than single executions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/20/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moore Michael

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LOUISIANA 70508

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/18/2026		S		31,570	D	$9.42(1)	1,691,044	I	by Moore Faster LLC
Common Shares	03/19/2026		S		40,232	D	$9.21(2)	1,650,812	I	by Moore Faster LLC
Common Shares	03/20/2026		S		65,000	D	$8.77(3)	1,585,812	I	by Moore Faster LLC
Common Shares								189,090	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.26 to $9.61. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.04 to $9.38. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.63 to $9.18. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)